Ultrasound-Mediated Nail Drug Delivery System

被引:21
作者
Abadi, Danielle [1 ]
Zderic, Vesna [1 ]
机构
[1] George Washington Univ, Dept Elect & Comp Engn, Washington, DC 20052 USA
关键词
drug delivery; low-intensity ultrasound; nail diseases; onychomycosis; LOW-FREQUENCY ULTRASOUND; ONYCHOMYCOSIS; PREVALENCE;
D O I
10.7863/jum.2011.30.12.1723
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
A novel ultrasound-mediated drug delivery system has been developed for treatment of a nail fungal disorder (onychomycosis) by improving delivery to the nail bed using ultrasound to increase the permeability of the nail. The slip-in device consists of ultrasound transducers and drug delivery compartments above each toenail. The device is connected to a computer, where a software interface allows users to select their preferred course of treatment. In in vitro testing, canine nails were exposed to 3 energy levels (acoustic power of 1.2 W and exposure durations of 30, 60, and 120 seconds). A stereo-microscope was used to determine how much of a drug-mimicking compound was delivered through the nail layers by measuring brightness on the cross section of each nail tested at each condition, where brightness level decreases coincide with increases in permeability. Each of the 3 energy levels tested showed statistical significance when compared to the control (P < .05) with a permeability factor of 1.3 after 30 seconds of exposure, 1.3 after 60 seconds, and 1.5 after 120 seconds, where a permeability factor of 1 shows no increase in permeability. Current treatments for onychomycosis include systemic, topical, and surgical. Even when used all together, these treatments typically take a long time to result in nail healing, thus making this ultrasound-mediated device a promising alternative.
引用
收藏
页码:1723 / 1730
页数:8
相关论文
共 21 条
[1]  
Cantrell JT, 2000, J PHARM SCI-US, V89, P1170, DOI 10.1002/1520-6017(200009)89:9<1170::AID-JPS9>3.0.CO
[2]  
2-9
[3]   Novel Treatment of Onychomycosis using Over-the-Counter Mentholated Ointment: A Clinical Case Series [J].
Derby, Richard ;
Rohal, Patrick ;
Jackson, Constance ;
Beutler, Anthony ;
Olsen, Cara .
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2011, 24 (01) :69-74
[4]   Effect of onychomycosis on quality of life [J].
Drake, LA ;
Scher, RK ;
Smith, EB ;
Faich, GA ;
Smith, SL ;
Hong, JJ ;
Stiller, MJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) :702-704
[5]   Medical and non-medical protection standards for ultrasound and infrasound [J].
Duck, Francis A. .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2007, 93 (1-3) :176-191
[6]   Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions [J].
Elewski, BE ;
Charif, MA .
ARCHIVES OF DERMATOLOGY, 1997, 133 (09) :1172-1173
[7]  
Gupta AK, 1998, BRIT J DERMATOL, V139, P665, DOI 10.1046/j.1365-2133.1998.02464.x
[8]   Breaking barriers in transdermal drug delivery [J].
Hampton, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2083-2083
[9]  
*INT EL COMM, 2001, 60601 IEC 2
[10]   Heterogeneity in skin treated with low-frequency ultrasound [J].
Kushner, Joseph ;
Blankschtein, Daniel ;
Langer, Robert .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (10) :4119-4128